drugset / Trial / NCT03960957
Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines
RandomizedParallel-groupDouble-blindTreatment
Summary
An interventional phase 3 study to evaluate efficacy and safety of a new dilution and injection volume of AbobotulinumtoxinA treatment for glabellar lines
Timeline
- Start
- 2019-06-17
- Primary completion
- 2019-09-27
- Completion
- 2020-04-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 50 unknown | — |
Indications
No indication recorded.